苦参
体内
化学
膜联蛋白
肝星状细胞
药理学
细胞凋亡
体外
纤维化
基因敲除
信号转导
细胞生长
细胞
穿心莲内酯
类黄酮
癌症研究
肝损伤
细胞生物学
肝纤维化
细胞培养
细胞信号
肝细胞
离体
肌成纤维细胞
河马信号通路
作者
Xingjun Chen,Qian Wang,Mu-zhen Wang,Xu Zhang,Shang‐Gao Liao,Zhu Zeng,Xiaopeng Li,Lihui Wang,Bo Tu,Yan Lin
标识
DOI:10.3389/fphar.2026.1948257
摘要
Introduction Sophora flavescens is traditionally used in TCM and Miao/Mongolian/Yi ethnomedicines for hepatobiliary disorders, yet its bioactive flavonoid constituents and mechanisms remain incompletely understood. This study investigated the anti-hepatic fibrosis efficacy, mechanism, and target of the ethyl acetate fraction (EAF) from S. flavescens and its key lavandulyl flavonoid kurarinol A (KA). Methods A CCl4-induced mouse hepatic fibrosis model was established to evaluate liver injury and fibrosis by H&E/Masson staining and detection of serum ALT/AST and hepatic α-SMA/fibronectin/Hyp. A TGF-β1-activated LX-2 cell model was established, with cell viability, migration, and apoptosis evaluated by MTS, wound-healing, and Annexin V-FITC/PI assays. Transcriptomics, KEGG analysis, molecular docking, Molecular dynamics (MD) simulation, CETSA, and MyD88 knockdown/overexpression assays were applied to explore the underlying mechanism. Results In vivo , EAF (50 and 100 mg/kg) alleviated CCl4-induced liver injury and fibrosis and decreased the levels of fibrotic serum biomarkers. In vitro , KA significantly inhibited LX-2 cell activation with an IC50 of 12.65 μM (n = 3), suppressing cell proliferation and migration while inducing apoptosis. KA’s anti-fibrotic activity was validated only in vitro , and its contribution to the in vivo efficacy of the EAF remains inferred rather than directly proven. Mechanistically, KA downregulated key signaling molecules of the TLR4/NF- κ B pathway, thereby blocking pathway activation. Molecular docking, MD simulations and CETSA supported a direct interaction between KA and MyD88. MyD88 knockdown and overexpression assays further supported that MyD88 serves as a candidate molecular target mediating KA’s anti-fibrotic activity. Conclusion The EAF exerts anti-fibrotic effects in vivo, and KA exhibits consistent anti-fibrotic activity in vitro . These findings support MyD88 as a potential molecular target mediating KA’s in vitro anti-fibrotic activity via TLR4/NF- κ B signaling. These findings not only validate the traditional use of S. flavescens in hepatobiliary disorders, but also offer a promising MyD88-targeting candidate warranting lead optimization for anti-fibrotic drug development.
科研通智能强力驱动
Strongly Powered by AbleSci AI